These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Oncology. Recruiting the cell's own guardian for cancer therapy. Marx J Science; 2007 Mar; 315(5816):1211-3. PubMed ID: 17332387 [No Abstract] [Full Text] [Related]
6. Researchers Turn to Canine Clinical Trials to Advance Cancer Therapies. Jacob JA JAMA; 2016 Apr; 315(15):1550-2. PubMed ID: 27027696 [No Abstract] [Full Text] [Related]
7. [The use of targeted therapies in oncology and their impact in the design of clinical trials: epidermal growth factor receptors 1 and 2 as a paradigm]. Dalmases A; Rojo F; Rovira A; Albanell J Med Clin (Barc); 2013 Aug; 141(4):176-80. PubMed ID: 23809407 [No Abstract] [Full Text] [Related]
8. Modeling therapy resistance in genetically engineered mouse cancer models. Rottenberg S; Jonkers J Drug Resist Updat; 2008; 11(1-2):51-60. PubMed ID: 18165147 [TBL] [Abstract][Full Text] [Related]
9. Animal models of disease: pre-clinical animal models of cancer and their applications and utility in drug discovery. Ruggeri BA; Camp F; Miknyoczki S Biochem Pharmacol; 2014 Jan; 87(1):150-61. PubMed ID: 23817077 [TBL] [Abstract][Full Text] [Related]
11. The use of targeted mouse models for preclinical testing of novel cancer therapeutics. Olive KP; Tuveson DA Clin Cancer Res; 2006 Sep; 12(18):5277-87. PubMed ID: 17000660 [TBL] [Abstract][Full Text] [Related]
12. Learning from exceptional drug responders. Mullard A Nat Rev Drug Discov; 2014 Jun; 13(6):401-2. PubMed ID: 24875081 [No Abstract] [Full Text] [Related]
13. Genetically engineered animal models for in vivo target identification and validation in oncology. Texidó G Methods Mol Biol; 2013; 986():281-305. PubMed ID: 23436419 [TBL] [Abstract][Full Text] [Related]
14. Personalized-medicine trials on the rise. Benowitz S J Natl Cancer Inst; 2012 Oct; 104(19):1425-6. PubMed ID: 23008496 [No Abstract] [Full Text] [Related]
15. Cancer research. Obstacle for promising cancer therapy. Marx J Science; 2002 Feb; 295(5559):1444. PubMed ID: 11859164 [No Abstract] [Full Text] [Related]
16. Spontaneous and genetically engineered animal models; use in preclinical cancer drug development. Hansen K; Khanna C Eur J Cancer; 2004 Apr; 40(6):858-80. PubMed ID: 15120042 [TBL] [Abstract][Full Text] [Related]
17. The promise of genetically engineered mice for cancer prevention studies. Green JE; Hudson T Nat Rev Cancer; 2005 Mar; 5(3):184-98. PubMed ID: 15738982 [TBL] [Abstract][Full Text] [Related]
18. Mouse models of human cancer. Böck BC; Stein U; Schmitt CA; Augustin HG Cancer Res; 2014 Sep; 74(17):4671-5. PubMed ID: 25136075 [TBL] [Abstract][Full Text] [Related]
19. Post-translational modifications and regulation of the RAS superfamily of GTPases as anticancer targets. Konstantinopoulos PA; Karamouzis MV; Papavassiliou AG Nat Rev Drug Discov; 2007 Jul; 6(7):541-55. PubMed ID: 17585331 [TBL] [Abstract][Full Text] [Related]